Anti-NMDAR antibodies as a new piece in schizophrenia's puzzle.

Twenty (9%) of the patients had one or more of the neuronal cell surface antibodies in comparison with four (4%) of the controls, a difference that did not reach statistical significance even when adjusting for potential confounding factors.

also in 111,027 other papers